Unknown

Dataset Information

0

The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies.


ABSTRACT:

Purpose

The Göttingen minipig is a relevant non-rodent species for regulatory toxicological studies. Yet, its use with therapeutic antibodies has been limited by the unknown binding properties of human immunoglobulins (huIgG) to porcine Fc gamma receptors (poFcγR) influencing safety and efficacy readouts. Therefore, knowing IgG-FcγR interactions in the animal model is a prerequisite for the use of minipigs in preclinical safety and efficacy studies with therapeutic antibodies.

Methods

Here, we describe the cloning and expression of poFcγRs and their interactions with free and complexed human therapeutic IgG1 by surface plasmon resonance and flow cytometry.

Results

We show here that poFcγRIa, poFcγRIIa, and poFcγRIIb bind huIgG1 antibodies with comparable affinities as corresponding huFcγRs. Importantly, poFcγRs bind huIgG immune complexes with high avidity, thus probably allowing human-like effector functions. However, poFcγRIIIa binds poIgG1a but not to huIgG1.

Conclusions

The lack of binding of poFcγRIIIa to huIgG1 might cause underestimation of FcγRIIIa-mediated efficacy or toxicity as mediated by porcine natural killer cells. Therefore, the suitability of minipigs in preclinical studies with human therapeutic antibodies has to be assessed case by case. Our results facilitate the use of Göttingen minipigs for assessment of human therapeutic antibodies in preclinical studies.

SUBMITTER: Egli J 

PROVIDER: S-EPMC6373530 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Binding of Human IgG to Minipig FcγRs - Implications for Preclinical Assessment of Therapeutic Antibodies.

Egli Jerome J   Schlothauer Tilman T   Spick Christian C   Seeber Stefan S   Singer Thomas T   Odermatt Alex A   Iglesias Antonio A  

Pharmaceutical research 20190205 3


<h4>Purpose</h4>The Göttingen minipig is a relevant non-rodent species for regulatory toxicological studies. Yet, its use with therapeutic antibodies has been limited by the unknown binding properties of human immunoglobulins (huIgG) to porcine Fc gamma receptors (poFcγR) influencing safety and efficacy readouts. Therefore, knowing IgG-FcγR interactions in the animal model is a prerequisite for the use of minipigs in preclinical safety and efficacy studies with therapeutic antibodies.<h4>Methods  ...[more]

Similar Datasets

| S-EPMC7293622 | biostudies-literature
| S-EPMC5384711 | biostudies-literature
| S-EPMC9652145 | biostudies-literature
| S-EPMC9655775 | biostudies-literature
| S-EPMC8976721 | biostudies-literature
| S-EPMC3870831 | biostudies-literature
| S-EPMC4424065 | biostudies-literature
| S-EPMC5557095 | biostudies-literature
| S-EPMC5476644 | biostudies-literature
| S-EPMC4552657 | biostudies-literature